Telangana Govt teams up with Flanders Investment & Trade to promote Life Sciences industry

10 February 2023 | News

Flanders named the International Regional Partner at BioAsia 2023

image credit- shutterstock

image credit- shutterstock

Government of Telangana is partnering with Flanders in Belgium, to explore multiple opportunities in the Life Sciences sector aimed at vaccines and mRNA technological platforms, immunotherapy, university partnership and Cluster-to-Cluster collaborations.

Currently, the Flanders’ Life Scienes industry comprises of over 350 companies employing over 20,000 people including indirect jobs. The region has attracted in the Life Sciences & Pharma segment more than a quarter of the total record investment of $5.56 billion in 2022 into Flanders from across the globe. The total estimated Life Sciences business in Belgium is estimated around $44 billion.

Clusters in Flanders like FlanderBIO, VIB, would engage with the identified clusters in Hyderabad, including Genome Valley, Medtech Park in Telangana, to help companies explore market access, technology partnerships, joint venture opportunities, etc. The Government of Telangana intends to establish an Institute of Curative Medicine in Hyderabad that aims to develop and commercialize the latest age-appropriate therapies for diseases prevalent in this region. 

As the first step of this partnership, Flanders will be participating as International Region Partners for the next 3 editions of BioAsia starting with the forthcoming 20th edition of BioAsia – the marquee healthcare and life sciences event, organised by the Government of Telangana. 

A task force with members including industry, academia and government from both sides have been formed and the group will discuss and implement the partnership. BioAsia in Telangana and Knowledge for Growth in Flanders shall be the two anchor events on either side in which both ecosystems shall participate in these events to steer the Flanders Telangana Lifesciences Cooperation in the next 3 to 4 years.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account